New WHO Guideline on Testing of Counterfeit Medicines
Recommendation
Thursday, 17 February 2022 9 .00 - 16.30 h
Register now for ECA's GMP Newsletter
The World Health Organization (WHO) has published a new guideline that describes the procedure for checking supposedly counterfeit or suspect medicines.
The WHO distinguishes three types of "Suspect Medicines":
- "Out of specification" medicines
- Unregistered/unlicensed medicines
- Medicines that have been deliberately falsified.
The present guideline deals mainly with the third category. It contains technical assistance for sampling, laboratory testing of supposedly falsified medicinal products and the corresponding reporting. Examples of this can be found in the appendix of the document for
- Analysis methods for package identification
- An information collection form
- Content of a SOP for testing counterfeit tablets
- Flowcharts for the review procedure (decision tree)
Please visit the WHO website for the new WHO guidance testing of "suspect" falsified medicines.
Related GMP News
GMP Conferences by Topics
- General Quality Assurance and GMP Compliance Topics
- Hygiene
- General Microbiology Topics
- Regulatory Affairs
- Development
- General Analytics Topics
- Good Distribution Practice
- Sterile Manufacturing
- Computer Validation
- General Qualification/Validation Topics
- General Engineering Topics
- APIs/Excipients
- GMP Basic Training Courses
- Medical Devices and Combination Products
- Packaging and Packaging Material
- Data Integrity
- Qualified Person (QP)
- GMP Auditing
- Documentation
- Cleaning Validation
- General IT Compliance Topics
- Impurities
- OOS / OOE / OOT
- Material Testing
- Validation of Analytical Methods
- Analytical Instrument Qualification
- Stability Testing
- Microbiological Testing
- Technology
- General Manufacturing Topics
- Solid Dosage Forms/Semi-Solid Dosage Forms
- Biotechnology/Blood/ATMP
- Herbal Drug Products/Cannabis/Radiopharmaceuticals
- Others